InterventionsHuman trial

Efficacy and Safety of Mazdutide 9 mg in Chinese Adults with Obesity: Results from the Phase 3 GLORY-2 Trial

ADA Scientific Sessions 2026 Abstract

The paper

Linong Ji, Leili Gao, Hongwei Jiang,

Hanqing Cai, Junhang Tian, Bimin Shi, Wei Qiu, Yanqi Wang, Li Li, Qingyang Ma, DENG Huan, Lijuan Pei, Han Han‐Zhang,

Changchun

ADA Scientific Sessions 2026 Abstract · 7 Jun 2026

Presented at ADA Scientific Sessions 2026 · Oral 1225-OR

doi.org/10.2337/db26-1225-or

A triple-target drug cut body weight by up to 19.7% in a trial
Cell Metabolism · 8 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026